Sonoma Pharmaceuticals Inc
格付け機関評価
Sonoma Pharmaceuticals Inc
SNOA
1
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
34
指標
本指標機能は、各種テクニカル指標を用いて金融商品の数値分析と方向性評価を提供し、技術的な要約を表示します。
本機能ではMACD・RSI・KDJ・StochRSI・ATR・CCI・WR・TRIX・MAの9種類の主要テクニカル指標を網羅しています。時間軸はご自身のニーズに合わせて調整可能です。
テクニカル分析は投資判断の一要素に過ぎず、数値による方向性評価に絶対的な基準はありません。表示結果はあくまで参考情報であり、指標計算・要約の正確性について当方は責任を負いかねます。
財務指標
EPS

データなし
総売上高

データなし
企業名
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
企業コードSNOA
企業名Sonoma Pharmaceuticals Inc
最高経営責任者「CEO」Ms. Amy Trombly
ウェブサイトhttps://sonomapharma.com/